Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation
Active, not recruiting · NCT04395222 · Registry updated 2026-01-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Tocilizumab for the Prevention of Graft Failure and GVHD in Haplo-Cord Transplantation | Hemic and Lymphatic Diseases, Neoplasms by Site, hematologic disorder, hematopoietic and lymphoid system neoplasm, neoplasm | Active, not recruiting | Phase 2 | 2026-01-06 | NCT04395222 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Weill Medical College of Cornell University | 276 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Weill Cornell Medical College | New York | United States | 58 |